Evaluation of the Prognostic Value of the Suppression Ratio Evaluated by BIS Among Patients Admitted to the ICU for Cardiac Arrest
SACRE
1 other identifier
interventional
102
1 country
1
Brief Summary
The aim of this study is to evaluate the prognostic value of the suppression ratio monitored by Bispectral Index for prediction of neurologic outcome after cardiac arrest. All patient admitted to our intensive care unit after a cardiac arrest are included. The results of the suppression ratio will be collected in the 6 first hours of admission. We will evaluate the link between suppression ratio and cerebral performance category score collected at three months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 12, 2016
CompletedFirst Posted
Study publicly available on registry
August 17, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedAugust 17, 2016
August 1, 2016
2.1 years
August 12, 2016
August 12, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Cerebral Performance Category score
3 months
Study Arms (1)
Single arm
EXPERIMENTALarm wherein all patients Suppression Ratio evaluated by BIS will be collected
Interventions
Eligibility Criteria
You may qualify if:
- Adult
- Cardiac arrest admitted to the ICU
You may not qualify if:
- \- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU Besançon
Besançon, 25000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François Belon, MD
CHRU Besançon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2016
First Posted
August 17, 2016
Study Start
August 1, 2012
Primary Completion
September 1, 2014
Study Completion
May 1, 2017
Last Updated
August 17, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share